Cited by 134Metabolism and Genetic DisordersLysosomal Storage Disorders ResearchGenomics and Rare Diseases

Mutation analysis ofPEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype

Open access
Braverman, Nancy, Chen, Li, Lin, Paul, Obie, Cassandra, Steel, Gary, Douglas, Pamela, Chakraborty, Pranesh K., Clarke, Joe T.R. +4 more·2002·Human Mutation

Abstract

PEX7 encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Mutations in PEX7 cause rhizomelic chondrodysplasia punctata (RCDP), a distinct peroxisome biogenesis disorder. In previous work we described three novel PEX7 mutant alleles, including one, L292X, with a high frequency due to a founder effect. We have now extended our analysis to 60 RCDP probands and identified a total of 24 PEX7 alleles, accounting for 95% of the mutant PEX7 genes in our sample. Of these, 50% are L292X, 13% are IVS9+1G>C, and the remainder are mostly private. IVS9+1G>C occurs on at least three different haplotypes and thus appears to result from recurrent mutation. The phenotypic spectrum of RCDP is broader than commonly recognized and includes minimally affected individuals at the mild end of the spectrum. To relate PEX7 genotype and phenotype, we evaluated the consequence of the disease mutation on PEX7 RNA by Northern analysis and RT/PCR. We evaluated the function of the encoded Pex7 protein (Pex7p) by expressing selected alleles in fibroblasts from RCDP patients and assaying their ability to restore import of a PTS2 marker protein. We find that residual activity of mutant Pex7p and reduced amounts of normal Pex7p are associated with milder and variant phenotypes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/humu.10124

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RCDP severity varies remarkably and depends strongly on residual activity of the affected enzyme and thus the level of plasmalogens.

    “The severity of the disease varies remarkably, depending strongly on the residual activity of the affected enzyme and, thus, the level of plasmalogens [188–191].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [190]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Braverman, N., Chen, L., Lin, P., Obie, C., Steel, G., Douglas, P., Chakraborty, P. K., Clarke, J. T. R., Boneh, A., Moser, A., Moser, H., & Valle, D.
Affiliations
  • Johns Hopkins University (US)
  • Howard Hughes Medical Institute (US)
  • Hospital for Sick Children (CA)
  • Royal Children's Hospital (AU)
  • Kennedy Krieger Institute (US)
Corresponding author
Braverman, Nancy
Venue
Human Mutation
Published
2002-09-24
Volume
20
Issue
4
Pages
284-297
ISSN
  • 1059-7794 (ISSN-L)
  • 1098-1004
OpenAlex
W1987179081
Cited by
134
References
52
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 2 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 10
FWCI
3.50
Type
journal article
Language
en
Open access
Locations
  • Human Mutation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (1RO1HD39747, P01HD10981, P01HD010981, R01HD039747)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
PEX7, rhizomelic chondrodysplasia punctata, peroxisome biogenesis disorders, founder effect, genotype-phenotype correlation, peroxisomal matrix protein import, haplotypes
MeSH terms
Peroxisomal Targeting Signal 2 Receptor, Adolescent, Amino Acid Sequence, Child, Child, Preschool, DNA Mutational Analysis, Genotype, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Phenotype, Receptors, Cytoplasmic and Nuclear, Founder Effect, Chondrodysplasia Punctata, Rhizomelic, Amino Acid Substitution, Protein Structure, Quaternary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review